BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6575697)

  • 21. [Hemostatic mechanisms and malignant tumors].
    Kase F; Pospísil J; Hlousková D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(6):809-30. PubMed ID: 2419210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibrinopeptide A in liver cirrhosis: evidence against a major contribution of disseminated intravascular coagulation to coagulopathy of chronic liver disease.
    Mombelli G; Fiori G; Monotti R; Haeberli A; Straub PW
    J Lab Clin Med; 1993 Jan; 121(1):83-90. PubMed ID: 8426084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radioimmunoassays of human fibrinopeptides A and B.
    Budzyński AZ; Marder VJ
    Pol Arch Med Wewn; 1978 Jan; 59(1):43-8. PubMed ID: 349523
    [No Abstract]   [Full Text] [Related]  

  • 24. Measurement of cross linked fibrin derivatives in plasma: an immunoassay using monoclonal antibodies.
    Whitaker AN; Elms MJ; Masci PP; Bundesen PG; Rylatt DB; Webber AJ; Bunce IH
    J Clin Pathol; 1984 Aug; 37(8):882-7. PubMed ID: 6206097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibrin(ogen) peptides in early breast cancer.
    Mannucci PM; Cugno M; Mameli G; Marongiu F; Bianchi Bonomi A
    Thromb Haemost; 1989 Sep; 62(2):819. PubMed ID: 2814934
    [No Abstract]   [Full Text] [Related]  

  • 26. Clottability and cross-linking reactivity of fibrin(ogen) following differential release of fibrinopeptides A and B.
    Furlan M; Seelich T; Beck EA
    Thromb Haemost; 1976 Dec; 36(3):582-92. PubMed ID: 14415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radioimmunoassay of fibrinopeptides in relation to intravascular coagulation and thrombosis.
    Nossel HL
    N Engl J Med; 1976 Aug; 295(8):428-32. PubMed ID: 59314
    [No Abstract]   [Full Text] [Related]  

  • 28. Low solubility fibrinogen examined by two-dimensional sodium dodecyl sulfate gel electrophoresis and isoelectric focusing.
    Weinstein MJ; Deykin D
    Thromb Res; 1978 Sep; 13(3):361-77. PubMed ID: 741433
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of divalent cations on the conversion of fibrinogen to fibrin and fibrin polymerization.
    Kanaide H; Uranishi T; Nakamura M
    Am J Hematol; 1982 Nov; 13(3):229-37. PubMed ID: 7180836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibrinopeptide A and intravascular coagulation in normotensive and hypertensive pregnancy and parturition.
    Wallmo L; Karlsson K; Teger-Nilsson AC
    Acta Obstet Gynecol Scand; 1984; 63(7):637-40. PubMed ID: 6516813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. D-dimer assays in diagnosis and management of thrombotic and bleeding disorders.
    Bates SM
    Semin Thromb Hemost; 2012 Oct; 38(7):673-82. PubMed ID: 23041982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of D dimer-E complex in disseminated intravascular coagulation.
    Whitaker AN; Rowe EA; Masci PP; Gaffney PJ
    Thromb Res; 1980 May 1-15; 18(3-4):453-9. PubMed ID: 6774434
    [No Abstract]   [Full Text] [Related]  

  • 33. The D-dimer assay.
    Johnson ED; Schell JC; Rodgers GM
    Am J Hematol; 2019 Jul; 94(7):833-839. PubMed ID: 30945756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discrepant elimination of fibrin des-AA and des-AABB in man.
    Nilsen DW; Brosstad F
    Thromb Haemost; 1986 Jun; 55(3):439. PubMed ID: 3750275
    [No Abstract]   [Full Text] [Related]  

  • 35. The sequence of cleavage of fibrinopeptides from fibrinogen is important for protofibril formation and enhancement of lateral aggregation in fibrin clots.
    Weisel JW; Veklich Y; Gorkun O
    J Mol Biol; 1993 Jul; 232(1):285-97. PubMed ID: 8331664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical significance of fibrinogen/fibrin degradation products (F/F DP)].
    Alakhverdian R
    Vutr Boles; 1979; 18(3):160-7. PubMed ID: 89851
    [No Abstract]   [Full Text] [Related]  

  • 37. Relationship between fibrinopeptide A and fibrinogen/fibrin fragment E in thromboembolism, DIC and various non-thromboembolic diseases.
    Mombelli G; Monotti R; Haeberli A; Straub PW
    Thromb Haemost; 1987 Aug; 58(2):758-63. PubMed ID: 3672428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Analysis of cross-linked fibrin and fibrinogen degradation products with SDS-PAGE and immunoblot].
    Okumura N; Kagiya H; Kumagai T; Kameko M; Tozuka M; Saito H; Katsuyama T; Kanai M
    Rinsho Byori; 1990 Feb; 38(2):201-7. PubMed ID: 2329722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Interaction of fibrinogen with two forms of fibrin differing in the degree of activation by thrombin].
    Belitser VA; Lugovskoĭ EV; Ugarova TP; Derzskaia SG
    Biokhimiia; 1985 Aug; 50(8):1336-41. PubMed ID: 4074798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinction between fibrinogen and fibrin degradation products produced during disseminated intravascular coagulation in childhood.
    Yoshioka K; Mizuno S; Miyata H; Maki S
    Eur J Pediatr; 1982 Feb; 138(1):46-8. PubMed ID: 7075627
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.